These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18289027)

  • 21. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
    Mitsumoto H; Brooks BR; Silani V
    Lancet Neurol; 2014 Nov; 13(11):1127-1138. PubMed ID: 25316019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyotrophic Lateral Sclerosis: An Update for 2018.
    Oskarsson B; Gendron TF; Staff NP
    Mayo Clin Proc; 2018 Nov; 93(11):1617-1628. PubMed ID: 30401437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis.
    Hodgkinson VL; Lounsberry J; Mirian A; Genge A; Benstead T; Briemberg H; Grant I; Hader W; Johnston WS; Kalra S; Linassi G; Massie R; Melanson M; O'Connell C; Schellenberg K; Shoesmith C; Taylor S; Worley S; Zinman L; Korngut L
    Can J Neurol Sci; 2018 Nov; 45(6):652-659. PubMed ID: 30430962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Riluzole does not improve lifespan or motor function in three ALS mouse models.
    Hogg MC; Halang L; Woods I; Coughlan KS; Prehn JHM
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):438-445. PubMed ID: 29221425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning.
    Kumar V; Islam A; Hassan MI; Ahmad F
    Eur J Med Chem; 2016 Oct; 121():903-917. PubMed ID: 27372371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Amyotrophic lateral sclerosis: update on etiological treatment].
    Ayach L; Curti C; Montana M; Pisano P; Vanelle P
    Therapie; 2013; 68(2):93-106. PubMed ID: 23773350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Update on fundamental and clinical research in amyotrophic lateral sclerosis].
    Pradat PF; Camdessanché JP; Carluer L; Cintas P; Corcia P; Danel-Brunaud V; Echaniz-Laguna A; Gonzalez J; Nicolas G; Vandenberghe N; Verschueren A;
    Rev Neurol (Paris); 2009; 165(6-7):532-41. PubMed ID: 19419744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis.
    Dyer AM; Smith A
    Drug Des Devel Ther; 2017; 11():59-64. PubMed ID: 28053507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
    Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
    BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapies in amyotrophic lateral sclerosis-beyond riluzole.
    Morrison KE
    Curr Opin Pharmacol; 2002 Jun; 2(3):302-9. PubMed ID: 12020475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
    Noto Y; Shibuya K; Vucic S; Kiernan MC
    Expert Rev Neurother; 2016 Oct; 16(10):1147-54. PubMed ID: 27314534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects for gene replacement therapies in amyotrophic lateral sclerosis.
    Giovannelli I; Higginbottom A; Kirby J; Azzouz M; Shaw PJ
    Nat Rev Neurol; 2023 Jan; 19(1):39-52. PubMed ID: 36481799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease-modifying treatment of amyotrophic lateral sclerosis.
    Schultz J
    Am J Manag Care; 2018 Aug; 24(15 Suppl):S327-S335. PubMed ID: 30207671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of amyotrophic lateral sclerosis--what is the next step?
    Ludolph AC
    J Neurol; 2000 Dec; 247():13-8. PubMed ID: 11200700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
    Bellingham MC
    CNS Neurosci Ther; 2011 Feb; 17(1):4-31. PubMed ID: 20236142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel therapeutic targets for amyotrophic lateral sclerosis.
    Batra G; Jain M; Singh RS; Sharma AR; Singh A; Prakash A; Medhi B
    Indian J Pharmacol; 2019; 51(6):418-425. PubMed ID: 32029967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.
    Mandrioli J; Malerba SA; Beghi E; Fini N; Fasano A; Zucchi E; De Pasqua S; Guidi C; Terlizzi E; Sette E; Ravasio A; Casmiro M; Salvi F; Liguori R; Zinno L; Handouk Y; Rizzi R; Borghi A; Rinaldi R; Medici D; Santangelo M; Granieri E; Mussuto V; Aiello M; Ferro S; Vinceti M;
    J Neurol; 2018 Apr; 265(4):817-827. PubMed ID: 29404735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Riluzole for amyotrophic lateral sclerosis.
    Drug Ther Bull; 1997 Feb; 35(2):11-2. PubMed ID: 9282413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.